F

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Director Business Development - Search & Evaluation

Corporate StrategyConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A PhD in biological science or an MD with laboratory research experience is strongly preferred.
  • 3–7 years of post-degree experience, combining scientific and business expertise.
  • A strong network within the biotech and pharmaceutical industries, with the ability to leverage contacts to source early-stage assets.
  • An enthusiastic approach to networking, relationship building, and externally facing activities.
  • An outgoing, motivated, and creative approach to business development.
  • Curiosity and insight into the role of artificial intelligence in drug development, clinical trials, and business development.

Responsibilities

  • Lead deal-by-deal opportunity and asset teams from asset identification through transaction close.
  • Collaborate with the business development team to identify target outreach areas aligned with Formation Bio’s goals.
  • Own and manage one or more designated business development outreach areas, such as big pharma, biotech companies, or designated therapeutic areas.
  • Maximize activity and ensure high-quality deal flow in assigned outreach areas, developing a steady stream of opportunities.
  • Conduct initial triage of opportunities and evaluate potential deals before engaging the broader diligence team to ensure strategic fit.
  • Work cross-functionally with research and development, technology platform, and commercial teams to ensure smooth handoffs and successful transitions in the diligence process.

Desired Qualifications

  • Prior experience in biotech or pharmaceutical business development (search and evaluation), venture capital investing, or life sciences consulting is highly preferable.

About the Company

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Formation Bio uses an AI-driven platform to speed up drug development by focusing on clinical-stage assets. It acquires and advances these assets using flexible financing structures, aiming to shorten timelines and cut costs for bringing new drugs to market. The core product is the proprietary AI tools that help with drug selection, development planning, and improving overall efficiency, enabling partnerships and successful commercialization with pharmaceutical and biotech companies. Compared with competitors, Formation Bio combines a data-powered approach with adaptable financing and asset acquisition strategies to move assets forward quickly and cost-effectively. The goal is to make treatments more accessible and affordable by accelerating development and enabling faster, more predictable commercialization through AI-enhanced decision making and flexible funding options.

Company size
51-200
Company stage
Series D
Total funding
$530.3M
Headquarters
New York City, New York
Founded
2013

Recently Posted Jobs

Explore more opportunities at Formation Bio

See more jobs